Clinical Trial Update: Atorvastatin Using as a Possible Prophylaxis of Postoperative Atrial Fibrillation After Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating atorvastatin as prophylaxis for postoperative atrial fibrillation after cardiac surgery was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Fundación General Universidad de Valladolid | Conditions: Atrial Fibrillation | Phase 3 | Status: TERMINATED